These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 33230020)

  • 1. Decision making for transjugular intrahepatic portosystemic stent shunt in refractory ascites and variceal bleeding: MELD, or not MELD, that is the question.
    Pitton MB; Zimmermann T; Mildenberger P; Weinmann A; Kloeckner R; Düber C; Mittler J; Hoppe-Lotichius M; Otto G
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e214-e222. PubMed ID: 33230020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of artificial intelligence for prognostic prediction with the albumin-bilirubin and platelet-albumin-bilirubin for cirrhotic patients with acute variceal bleeding undergoing early transjugular intrahepatic portosystemic shunt.
    Zhong BY; Tang HH; Wang WS; Shen J; Zhang S; Li WC; Yin Y; Yang J; Liu F; Ni CF; Zhao JB; Zhu XL
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e153-e160. PubMed ID: 33177378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes After TIPS for Ascites and Variceal Bleeding in a Contemporary Era-An ALTA Group Study.
    Boike JR; Mazumder NR; Kolli KP; Ge J; German M; Jest N; Morelli G; Spengler E; Said A; Lai JC; Desai AP; Couri T; Paul S; Frenette C; Verna EC; Rahim U; Goel A; Gregory D; Thornburg B; VanWagner LB;
    Am J Gastroenterol; 2021 Oct; 116(10):2079-2088. PubMed ID: 34158464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.
    Bettinger D; Sturm L; Pfaff L; Hahn F; Kloeckner R; Volkwein L; Praktiknjo M; Lv Y; Han G; Huber JP; Boettler T; Reincke M; Klinger C; Caca K; Heinzow H; Seifert LL; Weiss KH; Rupp C; Piecha F; Kluwe J; Zipprich A; Luxenburger H; Neumann-Haefelin C; Schmidt A; Jansen C; Meyer C; Uschner FE; Brol MJ; Trebicka J; Rössle M; Thimme R; Schultheiss M
    J Hepatol; 2021 Jun; 74(6):1362-1372. PubMed ID: 33508376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt.
    Tejedor-Tejada J; Fuentes-Valenzuela E; García-Pajares F; Nájera-Muñoz R; Almohalla-Álvarez C; Sánchez-Martín F; Calero-Aguilar H; Villacastín-Ruiz E; Pintado-Garrido R; Sánchez-Antolín G
    Gastroenterol Hepatol; 2021 Nov; 44(9):620-627. PubMed ID: 33249114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures.
    Lee BT; Yang AH; Urban S; Kim KY; Ter-Oganesyan R; Yuan L; Han HH; Khemichian S; Kahn JA; Kim B
    Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):541-546. PubMed ID: 32398491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience.
    Kraglund F; Jepsen P; Amanavicius N; Aagaard NK
    Scand J Gastroenterol; 2019 Jul; 54(7):899-904. PubMed ID: 31203699
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic value of neutrophil-to-lymphocyte ratio in cirrhosis patients undergoing transjugular intrahepatic portosystemic shunt.
    Zhang W; Aryan M; Chen Z; Khan W; Thompson B; Kwenda E; Geller B; Morelli G
    Eur J Gastroenterol Hepatol; 2022 Apr; 34(4):435-442. PubMed ID: 34750323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing in-hospital mortality for salvage percutaneous transjugular intrahepatic portosystemic shunting in cirrhotic patients with recalcitrant variceal bleeding after failed endoscopic intervention.
    Krige JEJ; Jonas EG; Setshedi M; Beningfield SJ; Lotze UK; Bernon MM; Burmeister S; Kloppers JC
    S Afr Med J; 2023 Dec; 114(1):39-43. PubMed ID: 38525611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of Model for End-Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding.
    Walter A; Rudler M; Olivas P; Moga L; Trépo E; Robic MA; Ollivier-Hourmand I; Baiges A; Sutter O; Bouzbib C; Peron JM; Le Pennec V; Ganne-Carrié N; Garcia-Pagán JC; Mallet M; Larrue H; Dao T; Thabut D; Hernández-Gea V; Nault JC; Bureau C; Allaire M;
    Hepatology; 2021 Oct; 74(4):2085-2101. PubMed ID: 34018627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incrementally Expandable Transjugular Intrahepatic Portosystemic Shunts: Single-Center Experience.
    Cui J; Smolinski SE; Liu F; Xu D; Dulaimy K; Irani Z
    AJR Am J Roentgenol; 2018 Feb; 210(2):438-446. PubMed ID: 29261352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome and predictors of survival after TIPS insertion in patients with liver cirrhosis.
    Heinzow HS; Lenz P; Köhler M; Reinecke F; Ullerich H; Domschke W; Domagk D; Meister T
    World J Gastroenterol; 2012 Oct; 18(37):5211-8. PubMed ID: 23066315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
    Membreno F; Baez AL; Pandula R; Walser E; Lau DT
    J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MELD score for prediction of survival after emergent TIPS for acute variceal hemorrhage: derivation and validation in a 101-patient cohort.
    Casadaban LC; Parvinian A; Zivin SP; Lakhoo J; Minocha J; Knuttinen MG; Ray CE; Bui JT; Gaba RC
    Ann Hepatol; 2015; 14(3):380-8. PubMed ID: 25864219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergent rescue transjugular intrahepatic portosystemic shunt within 8 h improves survival in patients with refractory variceal bleed.
    Mukund A; Vasistha S; Jindal A; Patidar Y; Sarin SK
    Hepatol Int; 2023 Aug; 17(4):954-966. PubMed ID: 36787012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transjugular intrahepatic portosystemic shunt (TIPS) placement at index portal hypertensive decompensation (anticipant TIPS) in cirrhosis and the role of early intervention in variceal bleeding and ascites.
    Rajesh S; Philips CA; Betgeri SS; George T; Ahamed R; Mohanan M; Augustine P
    Indian J Gastroenterol; 2021 Aug; 40(4):361-372. PubMed ID: 34324168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of portosystemic gradient during transjugular intrahepatic portosystemic shunt achieves good outcome and reduces complications.
    Luo SH; Zhou MM; Cai MJ; Han SL; Zhang XQ; Chu JG
    World J Gastroenterol; 2023 Apr; 29(15):2336-2348. PubMed ID: 37124886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albumin-bilirubin grade versus MELD score for predicting survival after transjugular intrahepatic portosystemic shunt (TIPS) creation.
    Ronald J; Wang Q; Choi SS; Suhocki PV; Hall MD; Smith TP; Kim CY
    Diagn Interv Imaging; 2018 Mar; 99(3):163-168. PubMed ID: 29154015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of covered stents for transjugular intrahepatic portosystemic stent shunt in patients with variceal bleeding and refractory ascites secondary to cirrhosis.
    Mattock R; Tripathi D; O'Neill F; Craig J; Tanner J; Patch D; Aithal G
    BMJ Open Gastroenterol; 2021 Aug; 8(1):. PubMed ID: 34429322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.